The dynamic interplay between hyperandrogenism and hyperinsulinemia: Emerging role of Linagliptin and Empagliflozin versus Metformin therapy in nondiabetic women with polycystic ovarian syndrome.
Problem/Background: Polycystic ovarian syndrome (PCOS) is a widespread female endocrine condition

